A CONTROLLED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER TOTAL-BODY IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA OR MALIGNANT-LYMPHOMA

被引:0
|
作者
LINK, H
BOOGAERTS, MA
CARELLA, AM
FERRANT, A
GADNER, H
GORIN, NC
HARABACZ, I
HAROUSSEAU, JL
HERVE, P
HOLLDACK, J
KOLB, HJ
KRIEGER, O
LABAR, B
LINKESCH, W
MANDELLI, F
MARANINCHI, D
NAPARSTEK, E
NICOLAY, U
NIEDERWIESER, D
REIFFERS, J
RIZZOLI, V
SIEGERT, W
VERNANT, JP
DEWITTE, T
机构
[1] CATHOLIC UNIV LEUVEN, MED CTR, DEPT HEMATOL, B-3000 LOUVAIN, BELGIUM
[2] OSPED SAN MARTINO GENOVA, DEPT HEMATOL, GENOA, ITALY
[3] CLIN UNIV ST LUC, DEPT HEMATOL, B-1200 BRUSSELS, BELGIUM
[4] ST ANNA CHILDRENS HOSP, DEPT PEDIAT HEMATOL & ONCOL, VIENNA, AUSTRIA
[5] HOP ST ANTOINE, DEPT HEMATOL, F-75571 PARIS 12, FRANCE
[6] HOP HOTEL DIEU, DEPT HEMATOL, NANTES, FRANCE
[7] UNIV BESANCON, MED CTR, DEPT HEMATOL, F-25030 BESANCON, FRANCE
[8] UNIV MUNICH, MED CTR, DEPT HEMATOL, W-8000 MUNICH 2, GERMANY
[9] HANUSCH HOSP, DEPT LEUKEMIA RES & HEMATOL, VIENNA, AUSTRIA
[10] UNIV ZAGREB, MED CTR, DEPT HEMATOL, YU-41001 ZAGREB, CROATIA
[11] UNIV VIENNA, MED CTR, DEPT HEMATOL, A-1010 VIENNA, AUSTRIA
[12] UNIV ROME LA SAPIENZA, POLICLIN UMBERTO 1, DEPT HEMATOL, I-00185 ROME, ITALY
[13] INST J PAOLI I CALMETTES, DEPT HEMATOL, F-13009 MARSEILLE, FRANCE
[14] HADASSAH UNIV HOSP, DEPT BONE MARROW TRANSPLANTAT, JERUSALEM, ISRAEL
[15] UNIV INNSBRUCK, MED CTR, DEPT IMMUNOBIOL, A-6020 INNSBRUCK, AUSTRIA
[16] HOP HAUT LEVEQUE, DEPT HEMATOL, PESSAC, ITALY
[17] UNIV PARMA, MED CTR, DEPT HEMATOL, I-43100 PARMA, ITALY
[18] FREE UNIV BERLIN, KLINIKUM CHARLOTTENBURG, MED CTR, DEPT HEMATOL & ONCOL, W-1000 BERLIN 19, GERMANY
[19] HOP HENRI MONDOR, DEPT HEMATOL, F-94010 CRETEIL, FRANCE
[20] CATHOLIC UNIV NIJMEGEN, MED CTR, DEPT HEMATOL, NIJMEGEN, NETHERLANDS
[21] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2188 / 2195
页数:8
相关论文
共 50 条
  • [21] HIGH-DOSE CHEMOTHERAPY, FRACTIONATED TOTAL-BODY IRRADIATION, AND ALLOGENEIC MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA
    PHILLIPS, GL
    HERZIG, RH
    LAZARUS, HM
    FAY, JW
    GRIFFITH, R
    HERZIG, GP
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 480 - 488
  • [22] Lack of efficacy of thrombopoietin and granulocyte-macrophage colony-stimulating factor after total body irradiation and autologous bone marrow transplantation in Rhesus monkeys
    Hartong, SCC
    Neelis, KJ
    Visser, TP
    Wagemaker, G
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 753 - 759
  • [23] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) INSTEAD OF BONE-MARROW TRANSPLANTATION DURING MYELOABLATIVE CHEMOTHERAPY FOR REFRACTORY MALIGNANT-LYMPHOMA (RML)
    AVILES, A
    FERNANDEZ, E
    TALAVERA, A
    SOSA, R
    VASQUEZ, E
    BLOOD, 1994, 84 (10) : A166 - A166
  • [24] TOXICITY FROM RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (RHUGM-CSF) AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT)
    SHOGAN, JE
    BRANDT, SJ
    JONES, RB
    SHPALL, EJ
    GILBERT, CJ
    ATWATER, SK
    BOROWITZ, MJ
    BAST, RC
    KURTZBERG, J
    OETTE, DH
    PETERS, WP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 53 - 53
  • [25] SEVERE HEPATOTOXICITY FROM GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    PRINCE, HM
    CHENG, M
    CAMERON, RG
    KEATING, A
    BONE MARROW TRANSPLANTATION, 1995, 16 (01) : 195 - 197
  • [26] ACTIVATION OF LYMPHOCYTES INDUCED BY RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH MALIGNANT-LYMPHOMA
    HO, AD
    HAAS, R
    WULF, G
    KNAUF, W
    EHRHARDT, R
    HEILIG, B
    KORBLING, M
    SCHULZ, G
    HUNSTEIN, W
    BLOOD, 1990, 75 (01) : 203 - 212
  • [27] THE USE OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    NEMUNAITIS, J
    SINGER, JW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S15 - S18
  • [28] USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN AUTOLOGOUS MARROW TRANSPLANTATION FOR LYMPHOID MALIGNANCIES
    NEMUNAITIS, J
    SINGER, JW
    BUCKNER, CD
    HILL, R
    STORB, R
    THOMAS, ED
    APPELBAUM, FR
    BLOOD, 1988, 72 (02) : 834 - 836
  • [29] Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies
    Vose, JM
    Bierman, PJ
    Ruby, E
    Reed, EC
    Bishop, MR
    Tarantolo, S
    Kessinger, A
    Armitage, JO
    BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 951 - 956
  • [30] THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR TO ACCELERATE RECOVERY OF THE AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MAN
    DEVEREUX, S
    GOLDSTONE, AH
    PATTERSON, K
    LINCH, DC
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 103 - 103